Reduction of Mortality Prior to and During the First 90 Days of Dialysis Through a Renal Rehabilitation Program
1 other identifier
interventional
116
1 country
1
Brief Summary
The mortality rate of treated patients with end stage renal disease(ESRD)is 22 deaths patient-years at risk in 2006. Incident patients with ESRD are most vulnerable within the first 90 days of dialysis, with an annualized mortality rate of 50 deaths/100 patient years. The vast majority of these deaths are due to cardiovascular causes. As cardiac rehabilitation programs have shown a 20% reduction in one year overall mortality rate post myocardial infarction the investigator proposes that a similar type of rehabilitation program will also have a benificial effect on morbidity and mortality in patients with chronic kidney disease(CKD)and ESRD.The overall goal of this project is to study whether a renal rehabilitation program based on guided exercise implemented in patients with stage III and stage IV CKD can influence the mortality rate of these patients prior to and during the first 90 days of dialysis Hypothesis:The application of a guided exercise program (renal rehabilitation) instituted in patients with stage III or Stage IV CKD will decrease the mortality rate prior to the initiation of renal replacement therapy. Hypothesis:The application of renal rehabilitation during the late stages of CKD will decrease the mortality risk during the first 90 days of renal rehabilitation therapy. Hypothesis:A guided exercise program will have an immediate and prolonged effect on activity levels, mental health and adaption to chronic illness in patients with advanced CKD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2008
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 14, 2008
CompletedFirst Posted
Study publicly available on registry
November 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2015
CompletedMay 30, 2017
May 1, 2017
7.1 years
November 14, 2008
May 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mortality prior to and During the First 90 Days of Dialysis
5 years
Secondary Outcomes (1)
Measurement of physical fitness and quality of life
5 years
Study Arms (2)
exercise training/renal rehabilitation
EXPERIMENTALExperimental arm will undergo 12 weeks of training in exercise, meditation, and nutrition education.
control
NO INTERVENTIONControl co-hort will receive usual chronic kidney disease care and no exercise, meditation or dietary education intervention.
Interventions
Subjects will undergo renal rehabilitation in the form of guided exercises 2 times per week for 3 months. Subjects will be encouraged to walk for 1 hour on their own a third day of the week.Subjects will receive recommendations for cardiovascular, weight training and stretching exercises. Cardiovascular and strength capabilities of all subjects will be evaluated at the initial session in order to prescribe the appropriate exercise regimen. An exercise physiologist will conduct these evaluations using the Perceived Level of Exertion Subjects will also receive education and practice in mindful meditation and a heart healthy diet. Subjects will be encouraged to continue exercises, meditation, and healthy eating habits after the 3-month in-center program. Subjects will receive follow-up phone calls at 3-month intervals to encourage ongoing exercise, meditation, and healthy diet.
Eligibility Criteria
You may qualify if:
- greater than 18 yo
- stage III CKD (GFR\<60ml/min)
- stage IV CKD (GFR\<30ml/min)
You may not qualify if:
- active angina pectoris
- lower extremity amputation with no prosthesis
- orthopedic disorder severly exacerbated by activity
- chronic lung disease resulting in significant shortness of breath or oxygen de-saturation at rest
- cerebro cascular disease manifested by ongoing TIAs
- malignant carcinoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MaineHealthlead
Study Sites (1)
Maine Nephrology Associates
Portland, Maine, 04102, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
November 14, 2008
First Posted
November 18, 2008
Study Start
October 1, 2008
Primary Completion
November 1, 2015
Study Completion
November 1, 2015
Last Updated
May 30, 2017
Record last verified: 2017-05